Chronic FXR activation with OCA is a potential strategy for activating IL-10/IL-10R signalling, reversing cardiac regulatory T cell dysfunction, and improving inflammasome-mediated NASH-related cardiac dysfunction. The gene discussed is IL10; the disease is metabolic dysfunction-associated steatohepatitis.